Alkermes (ALKS) Non-Current Assets (2011 - 2026)
Alkermes (ALKS) reported Non-Current Assets of $2.9 billion for Q1 2026, up 380.89% year-over-year from $602.9 million in Q1 2025, and up 419.77% quarter-over-quarter from $557.8 million in Q4 2025.
Alkermes (ALKS) Non-Current Assets (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Non-Current Assets data on file, last reported at $2.9 billion in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $2.9 billion, up 380.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.7 billion (up 86.59% YoY), and the FY2025 annual result was $557.8 million, down 12.87% from the prior year.
- Non-Current Assets climbed to $2.9 billion in Q1 2026 per ALKS's latest filing, from $557.8 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $2.9 billion in Q1 2026 and troughed at $557.8 million in Q4 2025.
- A 5-year average of $851.8 million and a median of $664.7 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets retreated 27.42% in 2024, then soared 380.89% in 2026.
- A 5-year view of Non-Current Assets shows it stood at $833.7 million in 2022, then declined by 21.95% to $650.7 million in 2023, then dropped by 1.61% to $640.2 million in 2024, then fell by 12.87% to $557.8 million in 2025, then soared by 419.77% to $2.9 billion in 2026.
- Business Quant data shows ALKS's Non-Current Assets at $2.9 billion in Q1 2026, $557.8 million in Q4 2025, and $587.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 68.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.90 Bn |
| Dec 31, 2025 | 557.83 Mn |
| Sep 30, 2025 | 587.85 Mn |
| Jun 30, 2025 | 617.52 Mn |
| Mar 31, 2025 | 602.93 Mn |
| Dec 31, 2024 | 640.21 Mn |
| Sep 30, 2024 | 591.11 Mn |
| Jun 30, 2024 | 664.65 Mn |
| Mar 31, 2024 | 655.07 Mn |
| Dec 31, 2023 | 650.72 Mn |
| Sep 30, 2023 | 814.45 Mn |
| Jun 30, 2023 | 789.83 Mn |
| Mar 31, 2023 | 812.67 Mn |
| Dec 31, 2022 | 833.67 Mn |
| Sep 30, 2022 | 888.10 Mn |
| Jun 30, 2022 | 911.43 Mn |
| Mar 31, 2022 | 963.02 Mn |
| Dec 31, 2021 | 962.32 Mn |
| Sep 30, 2021 | 942.43 Mn |
| Jun 30, 2021 | 899.81 Mn |